{"version":3,"file":"siteMetadata.LHonPeCG.mjs","names":[],"sources":["https:/framerusercontent.com/modules/skS3wfCZQFQ8BrPsmORi/9wsJ7uNgHzjUpuiDl0pX/siteMetadata.js"],"sourcesContent":["// Generated by Framer (4f2ff2f)\nexport default function metadata(params,activeLocale){return{description:\"Endios Bio Is Pioneering New Therapeutics For ALS And Rare Neurological Diseases, Based On Breakthroughs From Harvard And CU Boulder, Targeting PEG10—a Newly Discovered Disease Driver.\",favicon:\"https://framerusercontent.com/assets/iLyp2qTOh8zParnWb3hW47sXVU.png\",robots:\"max-image-preview:large\",socialImage:\"https://framerusercontent.com/assets/1zU6dUojBW6HNzeFnnmm153daeM.png\",title:\"Endios Bio – ALS Therapeutics Innovation\"};}export const metadataVersion=1;\nexport const __FramerMetadata__ = {\"exports\":{\"default\":{\"type\":\"function\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"metadataVersion\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"__FramerMetadata__\":{\"type\":\"variable\"}}}"],"mappings":"2DACA,SAAwB,EAAS,EAAO,EAAa,CAAC,MAAM,CAAC,YAAY,2LAA2L,QAAQ,sEAAsE,OAAO,0BAA0B,YAAY,uEAAuE,MAAM,2CAA2C,AAAE"}